AllianceBernstein’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-98,894
| Closed | -$13M | – | 3348 |
|
|
2020
Q4 | $13M | Buy |
98,894
+79,594
| +412% | +$10.5M | 0.01% | 1007 |
|
|
2020
Q3 | $975K | Buy |
19,300
+300
| +2% | +$15.2K | ﹤0.01% | 2190 |
|
|
2020
Q2 | $906K | Buy |
19,000
+3,400
| +22% | +$162K | ﹤0.01% | 2246 |
|
|
2020
Q1 | $764K | Sell |
15,600
-1,100
| -7% | -$53.9K | ﹤0.01% | 2148 |
|
|
2019
Q4 | $958K | Sell |
16,700
-700
| -4% | -$40.2K | ﹤0.01% | 2290 |
|
|
2019
Q3 | $626K | Sell |
17,400
-1,600
| -8% | -$57.6K | ﹤0.01% | 2441 |
|
|
2019
Q2 | $591K | Buy |
19,000
+6,700
| +54% | +$208K | ﹤0.01% | 2528 |
|
|
2019
Q1 | $288K | Buy |
+12,300
| New | +$288K | ﹤0.01% | 2773 |
|